Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.
종목 코드 TWST
회사 이름Twist Bioscience Corp
상장일Oct 31, 2018
CEODr. Emily M. Leproust, Ph.D.
직원 수923
유형Ordinary Share
회계 연도 종료Oct 31
주소681 Gateway Blvd.
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호94080
전화18007190671
웹사이트https://www.twistbioscience.com/
종목 코드 TWST
상장일Oct 31, 2018
CEODr. Emily M. Leproust, Ph.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음